Your browser doesn't support javascript.
loading
Perceived barriers and benefits in the participation in faecal occult blood test colorectal cancer screening programme.
Menéndez Rodríguez, Martín; García-Morales, Natalia; Seoane Pillado, Teresa; Garau Ramírez, Jorge; Traver Salvador, Alba; Hervás Jiménez, Yésica; Pin Vieito, Noel; Menéndez Rodríguez, Luis; Cubiella, Joaquín.
Afiliación
  • Menéndez Rodríguez M; Primary Health Center Salceda de Caselas, Gerencia de Gestión Integrada de Vigo, SERGAS, Vigo, Spain; Area of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain. Electronic address: martinmenendezrodriguez@hotmail.com.
  • García-Morales N; Digestive Service, Complexo Hospitalario Universitario de Vigo Sergas, Vigo, Spain; South Galicia Health Research Institute, Vigo, Spain.
  • Seoane Pillado T; Unit of Preventive Medicine and Public Health, Department of Health Sciences, University of A Coruña-INIBIC, A Coruña, Spain.
  • Garau Ramírez J; Primary Health Center Chile, Área Hospital Clínic-Malvarrosa, Valencia, Spain.
  • Traver Salvador A; Primary Health Center Morella, Área de Salud de Vinaróz, Castellón, Spain.
  • Hervás Jiménez Y; Primary Health Center Chile, Área Hospital Clínic-Malvarrosa, Valencia, Spain.
  • Pin Vieito N; South Galicia Health Research Institute, Vigo, Spain; Digestive Service, Hospital Universitario de Ourense, Ourense, Spain.
  • Menéndez Rodríguez L; Psiquiatry Service, Hospital Universitario de A Coruña, A Coruña, Spain.
  • Cubiella J; South Galicia Health Research Institute, Vigo, Spain; Digestive Service, Hospital Universitario de Ourense, Ourense, Spain; Center for Biomedical Research Network for Liver and Digestive Diseases, Ourense, Spain.
Gastroenterol Hepatol ; 46(3): 185-194, 2023 Mar.
Article en En, Es | MEDLINE | ID: mdl-35605825
BACKGROUND: Colorectal cancer is the second cancer-related cause of death in the world. Tumour stage at diagnosis is the principal prognosis factor of survival. However, the participation in the programme is around 50%. The aim of the study was to identify the benefits and barriers perceived by the population when participating in a colorectal cancer screening programme with faecal occult blood test. METHODS: We carried out a cases-controls study with 408 participants. We analyzed epidemiological and social variables associated with lifestyle and behavioural factors based in the Health Belief Model. We conducted a descriptive analysis, and identified variables associated to adherence by a logistic regression. RESULTS: Variables independently associated with the participation in a colorectal cancer screening programme were age (OR 1.06; 95% CI: 1.01-1.11), having a stable partner (OR 1.96; 95% CI: 1.20-3.18), the level of education (OR 1.59; 95% CI: 1.02-2.47) and two of the barriers to participate in the faecal occult blood test screening: "you don't know how to do one" (OR=0.46; 95% CI: 0.23-0.93) and "it is not that important right now" (OR=0.43; 95% CI: 0.24-0.78). CONCLUSION: The existing barriers for screening with faecal occult blood test are the best factor predicting. This is relevant when designing the intervention programmes, as they should focus on reducing perceived barriers to increase the participation in colorectal cancer screening, thereby reducing colorectal cancer mortality.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Sangre Oculta Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Aspecto: Implementation_research Límite: Humans Idioma: En / Es Revista: Gastroenterol Hepatol Año: 2023 Tipo del documento: Article Pais de publicación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Sangre Oculta Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Aspecto: Implementation_research Límite: Humans Idioma: En / Es Revista: Gastroenterol Hepatol Año: 2023 Tipo del documento: Article Pais de publicación: España